Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Change in Cash (2014 - 2025)

Mesoblast (MESO) posted Change in Cash of $22.5 million for Q2 2023, up 219.88% sequentially from -$18.8 million in Q1 2023, and up 239.23% YoY from $6.6 million in Q2 2022.

Analysis

Mesoblast (MESO) Change in Cash (2014 - 2025) Analysis & Trends

Mesoblast has reported Change in Cash for 8 years, with the latest figure at $22.5 million in Q2 2023.

  • Quarterly Change in Cash rose 239.23% year-over-year to $22.5 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $11.0 million (up 114.55% YoY) and the FY2025 annual result came in at $97.5 million, up 1274.3% from the prior year.
  • Change in Cash grew to $22.5 million in Q2 2023 per MESO's latest filing, from -$18.8 million in the prior quarter.
  • Over five years, Change in Cash peaked at $81.0 million in Q1 2021 and troughed at -$31.7 million in Q4 2020.
  • A 5-year average of -$439500.0 and a median of -$18.3 million in 2022 frame the typical range for Change in Cash.
  • The sharpest annual moves came in 2020 and 2021: Change in Cash plunged 208.58% in 2020, then soared 491.98% in 2021.
  • Over 5 years, Change in Cash stood at $46.4 million in 2019, then sank by 168.33% to -$31.7 million in 2020, then jumped by 33.25% to -$21.2 million in 2021, then rose by 12.66% to -$18.5 million in 2022, then soared by 221.59% to $22.5 million in 2023.
  • According to Business Quant data, Change in Cash over the past three periods registered $22.5 million, -$18.8 million, and -$18.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 649.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.60 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -185.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 427.25 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -2.94 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.42 Mn
10 Mesoblast 2.24 Bn 2.14 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 161.55 Mn
Jun 30, 2023 -1.22 Mn
Mar 31, 2023 48.80 Mn
Dec 31, 2022 67.62 Mn
Sep 30, 2022 1.34 Mn
Jun 30, 2022 120.17 Mn
Mar 31, 2022 76.76 Mn
Dec 31, 2021 94.85 Mn
Sep 30, 2021 1.84 Mn
Jun 30, 2021 136.88 Mn
Mar 31, 2021 80.96 Mn
Dec 31, 2020 -31.73 Mn
Sep 30, 2020 -21.71 Mn
Jun 30, 2020 129.33 Mn
Mar 31, 2020 9.94 Mn
Dec 31, 2019 30.59 Mn
Sep 30, 2019 -15.85 Mn
Jun 30, 2019 50.43 Mn
Mar 31, 2019 -6.69 Mn
Dec 31, 2018 55.28 Mn